Progetti FP7 coordinati da "Islensk erfdagreining ehf"
| # | ||||
|---|---|---|---|---|
| 1 | PROMARK Genetic prostate cancer variants as biomarkers of disease progression | 2008 | 4˙045˙219.00 | 2˙709˙577.00 |
| 2 | PSYCHGENE Copy Number Variation and Endophenotypes in Psychiatric Disorders | 2008 | 652˙085.00 | 652˙085.00 |
| 3 | CANCERGENE Identification and functional characterization of genetic cancer risk variants | 2008 | 1˙499˙773.00 | 1˙499˙773.00 |
| 4 | PSYCHCNVS Copy number variations conferring risk of psychiatric disorders in children | 2009 | 4˙291˙496.00 | 2˙999˙798.00 |
| 5 | PSYCHDPC Psychiatric Diagnostic and Prevention Consortium | 2012 | 1˙779˙259.00 | 1˙779˙259.00 |
Altri progetti
L'Ente islensk erfdagreining ehf partecipato anche in questi progetti.
- ADITEC (2011, participant)
- INTERPREGGEN (2011, participant)
- CRESTAR (2011, participant)
- EUROTAST (2011, participant)
- EPIPGX (2011, participant)
- NEUROMICS (2012, participant)
- EURO-TEAM (2012, participant)
- TS-EUROTRAIN (2012, participant)
- BBMRI-LPC (2013, participant)
- IMAGEMEND (2013, participant)
- AGGRESSOTYPE (2013, participant)
- NEUROPAIN (2014, participant)
- GEFOS (2008, participant)
- GEN2PHEN (2008, participant)
- FAD (2008, participant)
- TREAT OA (2008, participant)
- ENGAGE (2008, participant)
- BBMRI (2008, participant)
- MARKMD (2009, participant)
- PNEUMOPATH (2009, participant)
- NEXTGENE (2010, participant)
- COGANGS (2010, participant)
- EUROTARGET (2011, participant)